These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 11378632

  • 41. Lipid-lowering therapy--benefits and risks.
    Abinader EG.
    Isr Med Assoc J; 2007 Feb; 9(2):132-3; author reply 133-4. PubMed ID: 17354321
    [No Abstract] [Full Text] [Related]

  • 42. [Treatment of dyslipidemia in clinical practice].
    Paragh G, Harangi M.
    Orv Hetil; 2006 Mar 05; 147(9):389-94. PubMed ID: 16619956
    [Abstract] [Full Text] [Related]

  • 43. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
    Sarawate CA, Cziraky MJ, Stanek EJ, Willey VJ, Corbelli JC, Charland SL.
    Clin Ther; 2007 Jan 05; 29(1):196-209. PubMed ID: 17379061
    [Abstract] [Full Text] [Related]

  • 44. Niacin-based therapy for dyslipidemia: past evidence and future advances.
    Ito MK.
    Am J Manag Care; 2002 Sep 05; 8(12 Suppl):S315-22. PubMed ID: 12240703
    [Abstract] [Full Text] [Related]

  • 45. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
    Durrington PN, Tuomilehto J, Hamann A, Kallend D, Smith K.
    Diabetes Res Clin Pract; 2004 May 05; 64(2):137-51. PubMed ID: 15063607
    [Abstract] [Full Text] [Related]

  • 46. [Indications for decreasing lipid values. Patients with healthy hearts with low HDL clearly profit].
    MMW Fortschr Med; 2000 Nov 30; 142(48):68. PubMed ID: 11138292
    [No Abstract] [Full Text] [Related]

  • 47. Rational drug therapy of the hyperlipoproteinemias, Part II.
    Blum CB, Levy RI.
    Ration Drug Ther; 1986 Oct 30; 20(10):1-4. PubMed ID: 3472266
    [No Abstract] [Full Text] [Related]

  • 48. [Secondary coronary heart disease prevention. Will CEPT inhibitors be the next breakthrough?].
    Einecke D.
    MMW Fortschr Med; 2011 Dec 08; 153(49-50):17-8. PubMed ID: 22308584
    [No Abstract] [Full Text] [Related]

  • 49. Aggressive medical therapy for the prevention and treatment of coronary artery disease.
    Malloy MJ, Kane JP.
    Dis Mon; 1998 Jan 08; 44(1):1-40. PubMed ID: 9457050
    [No Abstract] [Full Text] [Related]

  • 50. [Big gaps in coronary heart disease prevention. Statins are not enough in dyslipidemia].
    MMW Fortschr Med; 2009 Nov 12; 151(46):48. PubMed ID: 20043395
    [No Abstract] [Full Text] [Related]

  • 51. [Treatment of disorders of lipid metabolism with the new lipid regulator X50].
    Reuter W, Herrmann W, Sauer I, Janowski K, Dorn H, Steinicke A.
    Z Gesamte Inn Med; 1986 Mar 01; 41(5):124-6. PubMed ID: 3754999
    [Abstract] [Full Text] [Related]

  • 52. Raising low levels of high-density lipoprotein cholesterol is an important target of therapy.
    Boden WE, Pearson TA.
    Am J Cardiol; 2000 Mar 01; 85(5):645-50, A10. PubMed ID: 11078282
    [Abstract] [Full Text] [Related]

  • 53. Drug treatment of dyslipoproteinemia.
    Hunninghake DB.
    Endocrinol Metab Clin North Am; 1990 Jun 01; 19(2):345-60. PubMed ID: 2192877
    [Abstract] [Full Text] [Related]

  • 54. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
    Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ.
    N Engl J Med; 2001 Nov 29; 345(22):1583-92. PubMed ID: 11757504
    [Abstract] [Full Text] [Related]

  • 55. Treating hyperlipidemia, Part III: Drug therapy.
    Smith DA, Karmally W, Brown WV.
    Geriatrics; 1987 Aug 29; 42(8):55-9, 62. PubMed ID: 3110017
    [Abstract] [Full Text] [Related]

  • 56. Gemfibrozil, lipids, and coronary risk.
    Rifkind BM.
    N Engl J Med; 1987 Nov 12; 317(20):1279-81. PubMed ID: 3313042
    [No Abstract] [Full Text] [Related]

  • 57. [Drug therapy of dyslipidemias].
    Fonda M, Cattin L, Guarnieri G.
    Recenti Prog Med; 2000 Nov 12; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract] [Full Text] [Related]

  • 58. 2nd International Symposium on Triglycerides and HDL: lipid abnormalities and their treatment.
    Bloomgarden ZT.
    Diabetes Care; 2005 Nov 12; 28(11):2795-802. PubMed ID: 16249560
    [No Abstract] [Full Text] [Related]

  • 59. HDL on the rise.
    Alpert JS.
    Health News; 1999 Sep 10; 5(11):4. PubMed ID: 10513254
    [No Abstract] [Full Text] [Related]

  • 60. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y, Yanagi K, Yamashita S, Takemura K, Matsuzawa Y.
    Nihon Rinsho; 1994 Jul 10; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.